Literature DB >> 8292634

Medical disorders in a cohort of New York city drug abusers: much more than HIV disease.

L S Brown1, M J Hickson, D C Ajuluchukwu, J Bailey.   

Abstract

We evaluated the medical histories, drug abuse patterns, sexual behaviors, serological studies for syphilis and hepatitis B infection and other laboratory studies in 1780 patients enrolled in New York City drug treatment clinics in 1987. HIV serology was available for 168 patients. Nearly seventy-five percent had at least one medical disorder and 57% one abnormal laboratory parameter. A history of gonorrhea, hepatitis B infection, pneumonia, and anemia was reported in 28%, 23%, 21%, and 20.7% of the patients, respectively. Fifty-seven percent of 168 patients tested HIV seropositive and 16% of 1,780 patients were tuberculin reaction positive. Given the considerable prevalence of medical disorders, in which early identification and intervention is possible, serious consideration should be given to extend the scope of drug abuse services to include primary medical care services targeted at the medical sequelae of drug abuse, and medical disorders not directly associated with either HIV disease or drug abuse.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8292634     DOI: 10.1300/J069v12n04_02

Source DB:  PubMed          Journal:  J Addict Dis        ISSN: 1055-0887


  3 in total

1.  Treating chronic pain in the presence of substance abuse.

Authors:  Ava H Stanley; Monika M Safford
Journal:  J Natl Med Assoc       Date:  2004-08       Impact factor: 1.798

Review 2.  Morphine for the treatment of pain in sickle cell disease.

Authors:  Mihir Gupta; Lilian Msambichaka; Samir K Ballas; Kalpna Gupta
Journal:  ScientificWorldJournal       Date:  2015-01-12

3.  Syringe access for the prevention of blood borne infections among injection drug users.

Authors:  Sharon Stancliff; Bruce Agins; Josiah D Rich; Scott Burris
Journal:  BMC Public Health       Date:  2003-11-21       Impact factor: 3.295

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.